Financial Performance - The company's operating revenue for Q1 2025 was ¥578,958,662.02, a decrease of 12.51% compared to ¥661,734,693.33 in the same period last year[5]. - Net profit attributable to shareholders was ¥18,697,551.59, down 15.10% from ¥22,022,583.38 year-on-year[5]. - The company's diluted earnings per share decreased by 18.75% to ¥0.13 from ¥0.16 in the previous year[5]. - Net profit for the period was ¥18,697,521.23, representing a decline of 15.8% from ¥22,036,852.40 in the same quarter last year[24]. - The total comprehensive income attributable to the parent company was 18,697,551.59, a decrease from 22,022,583.38 in the previous period, reflecting a decline of approximately 15.5%[26]. Cash Flow - The net cash flow from operating activities improved to -¥78,998,475.02, a 47.68% increase compared to -¥150,979,221.43 in the previous year[5]. - Cash inflow from operating activities totaled 597,491,427.43, down from 619,590,777.02, representing a decrease of about 3.5%[29]. - Cash outflow for purchasing goods and services was 631,754,433.85, a decrease from 723,441,709.96, indicating a reduction of approximately 12.7%[29]. - Net cash flow from investing activities was -15,964,365.69, a significant decline from 351,716,719.61 in the previous period[29]. - Cash flow from financing activities showed a net inflow of 141,964,229.48, compared to a net outflow of -235,816.68 in the previous period, marking a substantial turnaround[30]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,845,470,755.58, up 5.28% from ¥1,752,995,649.72 at the end of the previous year[5]. - Total liabilities increased to ¥408,561,027.87 from ¥332,949,682.78, which is a rise of 22.7%[22]. - The company's cash and cash equivalents rose to ¥433,522,158.23 from ¥385,571,281.22, an increase of 12.4%[20]. Inventory and Receivables - Inventory increased by 72.84% to ¥205,177,702.79, primarily due to a rise in finished goods[9]. - The company's accounts receivable decreased to ¥173,566,768.23 from ¥178,108,207.84, indicating a reduction of 2.9%[21]. Research and Development - Research and development expenses surged by 145.17% to ¥5,761,274.90, reflecting increased investment in R&D[11]. - Research and development expenses for the quarter were ¥5,761,274.90, up from ¥2,349,885.71, indicating a significant increase of 145.5%[25]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 12,189[14]. - Jiangsu Changshun Group Co., Ltd. holds 45.02% of shares, totaling 63,107,202 shares[14]. - The company has repurchased a total of 1,021,418 shares, accounting for 0.73% of the total share capital[17]. - The total amount spent on share repurchase is 17,908,435.10 RMB (excluding transaction fees)[17]. - The company has no preferred shareholders or changes in restricted shares during the reporting period[16]. - The top ten shareholders do not participate in margin trading or securities lending[16]. - The company has not disclosed any related party transactions among other shareholders[16].
长华化学(301518) - 2025 Q1 - 季度财报